McNeil advertising
This article was originally published in The Tan Sheet
Executive Summary
Tylenol advertising account, reportedly valued at $100 mil., has been awarded to Deutsch (New York), McNeil Consumer & Specialty Pharmaceuticals announces Nov. 26. Deutsch also received St. Joseph's aspirin account, valued at more than $20 mil. Accounts for heartburn OTCs Pepcid AC ($48 mil.) and Mylanta ($16 mil.) went to Alchemy, which, like Deutsch, is owned by Interpublic group. All accounts were previously handled by New York-based Saatchi & Saatchi, which developed new Maximum Strength Pepcid AC ads that broke Nov. 24...
You may also be interested in...
Novartis snags Saatchi & Saatchi
Novartis has selected Publicis Group's Saatchi & Saatchi unit as the advertising agency for its Consumer Health division. Triaminic and Theraflu are the two major cough/cold brands included in the deal, Saatchi & Saatchi said. The advertising firm worked on McNeil Consumer & Specialty Pharmaceuticals' Tylenol, Pepcid AC andMylanta brands for several years before the accounts were passed on to Deutsch and Alchemy in late 2003 (1"The Tan Sheet" Dec. 8, 2003, In Brief)...
Xtreme Tylenol: Wakeboarding, Olympics And Indie Film Festivals
Recent edgy Tylenol promotions, which contrast sharply with previous traditional ads, reflect a dramatic change in marketing that coincides with McNeil Consumer & Specialty Pharmaceuticals' decision to switch ad agencies last year
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.